NCT07872072Not yet recruiting
HomeCare Medication Management for People With Dementia
Behavioral Shifts in Dementia Patients Using Novel Pharmacy Home Robotics: A Cost-Effective Approach to Aging in Place
Source: ClinicalTrials.gov · Last updated 13 Oct 2026
Brief summary (registry, in English)
This study will evaluate whether the HomeCare medication management system can improve medication adherence and related outcomes for adults age 65 and older living with dementia, Alzheimer's disease, or related dementias. HomeCare is an internet-connected medication management device that can automate medication dispensing, monitor medication use, and provide alerts to caregivers. The system is integrated with a Pharmacy Distribution System designed to track medications from pharmacy delivery through use in the home. A total of 120 participants with dementia will be randomly assigned to one of two groups. One group will use the HomeCare system, while the other group will continue using standard medication management methods, such as pill bottles or blister packs. Participants will be followed for 12 months. The main outcome is medication adherence. The study will also examine hospitalizations and emergency room visits, cognitive function, caregiver burden, quality of life, satisfaction, and changes in medication-management behavior. Caregivers will also participate in surveys and study assessments. The study is intended to determine whether HomeCare can improve medication management and support both people living with dementia and their caregivers.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 7 Oct 2026
- Start date
- 1 Jan 2027
- Primary completion date
- 31 May 2027
- Lead sponsor
- HiDO Technologies
- Diseases
- Alzheimer disease
- NCT number
- NCT07872072
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 1 Jan 2027 to the primary completion date, 31 May 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Significant comorbidities or medical conditions that could interfere with participation or severe cognitive function.
- History of severe psychiatric illness or substance abuse disorder.
- Recent participation in other clinical trials targeting cognition or dementia.
Other
- Unwillingness or inability to comply with study procedures.
- Residence in a long-term care facility or institutional setting that may limit access to the home-based study intervention.
Who the study is looking for
- Age 65 years or older.
- Living with dementia, Alzheimer's Disease, or Alzheimer's Disease Related Dementias (AD/ADRD) according to standardized diagnostic criteria.
- Capable of providing informed consent or have a legally authorized representative available to consent on their behalf.
- Access to a smartphone, tablet, or computer with internet connectivity. Able to communicate in either English or Spanish.
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of California, Davis Coordinator of this site? Confirm its status | Davis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.